Asia Pacific Microcatheters Market Overview and Growth by 2027

The Asia Pacific microcatheters market is expected to reach US$ 166.98 million by 2027 from US$ 85.05 million in 2019; it is estimated to grow at a CAGR of 8.9% from 2020 to 2027.

The market growth is attributed to significantly increasing prevalence of chronic disorders, such as cardiovascular and neurovascular diseases, and rising elderly population across Asia Pacific. However, product recall and stringent regulatory requirement, and lack of expert professionals hinder the market growth.

Micro-catheters are delivery devices used in minimally invasive applications. These small catheters are ideal for navigating the vast network of tiny veins found within the body. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the most prominent cause of morbidity and mortality across the world. The CVDs include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and so on. As per the WHO data published in 2017, ~17.9 million people died from CVDs in 2016, which was 31.0% of all the global deaths in that year. Therefore, the significantly rising incidence of CVDs across Asia Pacific is likely to propel the demand for devices, such as microcatheters, that are required to treat these diseases. In addition, in the recent years, the prevalence of neurological disorders such as cerebral aneurysm has increased significantly across Asia Pacific, which fuelled the demand for microcatheters used in their treatment procedures. Also, the rising geriatric population leads to rise in cardiovascular disease and neurological disease, which is contributing to the growth of the Asia Pacific microcatheters market

Countries in Asia Pacific are facing challenges due to increasing incidence of COVID-19. The outbreak has restricted supply chain operations. Moreover, low-income countries are facing additional challenges due to the shortage of healthcare infrastructure and decreasing demand for neurovascular devices due to surging COVID-19 cases. Restrictive measures like complete lockdown by several countries are restricting supply chain and the availability of medical devices in these countries. Hence, obstructions in business activities such as the imposition of complete lockdown hamper the adoption of various technologically advanced healthcare systems, including microcatheters.

ASIA PACIFIC MICROCATHETERS MARKET SEGMENTATION

By Indication

• Neurovascular
• Coronary
• General Peripheral Vascular

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

By Country

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Company Profiles

• Boston Scientific Corporation
• Medtronic
• Merit Medical Systems Inc
• Terumo Corporation
• Penumbra, Inc
• Stryker Corporation
• Teleflex Incorporated
• Asahi Intecc USA, Inc.
• Tokai Medical Products, Inc.

Asia Pacific Microcatheters Report Scope